Written on: September 9, 2024 by SprayTM
BC3 Technologies, a privately held medical device company, announced that its SEAL Hemostatic Spray–an aerosolized chitosan for management of serious arterial bleeding–will be distributed by First Aid Only, an Acme United Corporation brand and provider of first aid solutions.
SEAL will be distributed through First Aid Only’s network of distribution partners, which provide a complete line of first aid products to manufacturing, construction, utilities and Government.
With First Aid Only’s recent acquisition of Elite First Aid, a supplier of tactical and emergency medical supplies, SEAL will also be distributed to law enforcement, EMS and fire-rescue services. In addition, Elite First Aid provides essential bleeding control for hunters and other outdoor enthusiasts.
“By partnering with First Aid Only and Elite First Aid, we are significantly enhancing our distribution capabilities and marking a significant milestone in our journey as a company,” says Wayne Grube, CEO and Co-Founder, BC3 Technologies.
“Our SEAL Hemostatic Spray will complement First Aid Only’s existing product lineup while their network allows us to place our life-saving product in the hands of those who need it most, boosting emergency response capabilities across various critical sectors,” Grube added.
BC3 Technologies received FDA clearance for SEAL in February 2023. In September 2023, BC3 Technologies launched the professional version of SEAL, which has been adopted by numerous police departments and EMS groups across the United States, and in July, introduced its 1.5 oz over-the-counter variant of SEAL.
“At First Aid Only, we are focused on critical wound care and are very happy to have created a partnership with BC3 Technologies,” said Janice Fowler, VP & GM – First Aid & Medical, Acme United Corporation.
“Having a bleeding control product in our assortment that is very easy for the lay person as well as the professional to use will be impactful in our ability to support the entirety of our customer base.”
Manufactured in Baltimore, MD, SEAL is designed to stop bleeding at the point of injury, providing immediate care and significantly increasing the chances of survival in emergency situations. When sprayed on a bleeding wound, SEAL quickly forms a strong barrier that helps stop bleeding within seconds and without pain.
SEAL is the first chitosan-based aerosol spray product available for treating wounds of its kind on the market, according to the company. Chitosan (pronounced: ky-toe-sin) is a linear polysaccharide composed of randomly distributed β-linked D-glucosamine and N-acetyl-D-glucosamine and can adhere to fibrinogen, which produces increased platelet adhesion, causing clotting of blood and hemostasis.
“Having a growing, innovative medical device company like BC3 Technologies based in Baltimore presents significant economic advantages and opportunities for Maryland and the region,” said Brian Castleberry, Senior Regional Manager, Maryland Dept. of Commerce.
“Their SEAL technology is poised to disrupt the medical device and emergency medical response industries, and we congratulate them on their new partnership with First Aid Only.”
Each year, 40% of critically wounded people with arterial bleeding die in transit to the hospital. Bleeding wounds, including gunshot wounds, that cannot be treated with standard hemostatic methods, such as applying pressure with bandages, remain a leading cause of potentially preventable deaths. Arterial bleeding also increases the chances of spreading blood borne diseases.
For more information on SEAL Hemostatic Wound Spray, visit https://www.bc3tech.com.
